The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Integrating Artificial Intelligence for Drug Discovery in the Context of Revolutionizing Drug Delivery
Open accessAbstract
Drug development is expensive, time-consuming, and has a high failure rate. In recent years, artificial intelligence (AI) has emerged as a transformative tool in drug discovery, offering innovative solutions to complex challenges in the pharmaceutical industry. This manuscript covers the multifaceted role of AI in drug discovery, encompassing AI-assisted drug delivery design, the discovery of new drugs, and the development of novel AI techniques. We explore various AI methodologies, including machine learning and deep learning, and their applications in target identification, virtual screening, and drug design. This paper also discusses the historical development of AI in medicine, emphasizing its profound impact on healthcare. Furthermore, it addresses AI’s role in the repositioning of existing drugs and the identification of drug combinations, underscoring its potential in revolutionizing drug delivery systems. The manuscript provides a comprehensive overview of the AI programs and platforms currently used in drug discovery, illustrating the technological advancements and future directions of this field. This study not only presents the current state of AI in drug discovery but also anticipates its future trajectory, highlighting the challenges and opportunities that lie ahead.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: Drug–target interaction prediction using artificial intelligence
Yaseen, B. T., & Kurnaz, S. (2021) · Applied Nanoscience · doi:10.1007/s13204-021-02000-5 · Cited by 10
RetractedHighly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Szklarczyk, D., Gable, A. L., Lyon, D., Junge, A., Wyder, S., Huerta-Cepas, J., Simonovic, M., Doncheva, N. T., Morris, J. H., Bork, P., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1131 · Cited by 17,749 · cited 1×
“It offers an abundance of information on protein–protein interactions across various organisms [85].”
BackgroundDrug repositioning: identifying and developing new uses for existing drugs
Ashburn, T. T., & Thor, K. B. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1468 · Cited by 3,237
MoleculeNet: a benchmark for molecular machine learning
Wu, Z., Ramsundar, B., Feinberg, E. N., Gomes, J., Geniesse, C., Pappu, A. S., Leswing, K., & Pande, V. (2018) · Chemical Science · doi:10.1039/c7sc02664a · Cited by 3,107 · cited 1×
“Significant progress has been made in various areas through the use of AI technology, including predicting molecular properties and activities [104–106], virtual screening [107,108], retrosynthetic analysis [109,110], and generating new drugs [111,112].”
BackgroundMachine learning and deep learning
Janiesch, C., Zschech, P., & Heinrich, K. (2021) · Electronic Markets · doi:10.1007/s12525-021-00475-2 · Cited by 2,959
Piñero, J., Bravo, À., Queralt-Rosinach, N., Gutiérrez-Sacristán, A., Deu-Pons, J., Centeno, E., García-García, J., Sanz, F., & Furlong, L. I. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw943 · Cited by 2,680
Unsupervised K-Means Clustering Algorithm
Sinaga, K. P., & Yang, M.-S. (2020) · IEEE Access · doi:10.1109/access.2020.2988796 · Cited by 2,244
Ertl, P., & Schuffenhauer, A. (2009) · Journal of Cheminformatics · doi:10.1186/1758-2946-1-8 · Cited by 1,939
Analyzing Learned Molecular Representations for Property Prediction
Yang, K., Swanson, K., Jin, W., Coley, C., Eiden, P., Gao, H., Guzman-Perez, A., Hopper, T., Kelley, B., Mathea, M., et al. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00237 · Cited by 1,923
Planning chemical syntheses with deep neural networks and symbolic AI
Segler, M. H. S., Preuss, M., & Waller, M. P. (2018) · Nature · doi:10.1038/nature25978 · Cited by 1,847
Artificial intelligence in drug discovery and development
Paul, D., Sanap, G., Shenoy, S., Kalyane, D., Kalia, K., & Tekade, R. K. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2020.10.010 · Cited by 1,695
STITCH 5: augmenting protein–chemical interaction networks with tissue and affinity data
Szklarczyk, D., Santos, A., von Mering, C., Jensen, L. J., Bork, P., & Kuhn, M. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1277 · Cited by 1,687
Artificial intelligence to deep learning: machine intelligence approach for drug discovery
Gupta, R., Srivastava, D., Sahu, M., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10217-3 · Cited by 1,473 · cited 2×
“Target validation may involve determining the genetic manipulation of target genes (knockdown drug-resistant mutant of the presumed target, using the e ff ects of the target, and monitoring the signaling presumed target [16].”
BackgroundLever, J., Krzywinski, M., & Altman, N. (2017) · Nature Methods · doi:10.1038/nmeth.4346 · Cited by 1,433
Computational approaches streamlining drug discovery
Sadybekov, A. V., & Katritch, V. (2023) · Nature · doi:10.1038/s41586-023-05905-z · Cited by 1,279
Deep Neural Nets as a Method for Quantitative Structure–Activity Relationships
Ma, J., Sheridan, R. P., Liaw, A., Dahl, G. E., & Svetnik, V. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/ci500747n · Cited by 1,159
Overview of artificial intelligence in medicine
Amisha, Malik, P., Pathania, M., & Rathaur, V. K. (2019) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_440_19 · Cited by 1,106 · cited 1×
“These robots can reduce the risk of complications, minimize invasiveness, and shorten These robots can reduce the risk of complications, minimize invasiveness, and shorten recovery times, leading to be tt er surgical outcomes [4]. recovery times, leading to better surgical outcomes [4].”
BackgroundDeepTox: toxicity prediction using deep learning
Mayr, A., Klambauer, G., Unterthiner, T., & Hochreiter, S. (2016) · Frontiers in Environmental Science · doi:10.3389/fenvs.2015.00080 · Cited by 1,081
Drug discovery with explainable artificial intelligence
Jiménez-Luna, J., Grisoni, F., & Schneider, G. (2020) · Nature Machine Intelligence · doi:10.1038/s42256-020-00236-4 · Cited by 1,063 · cited 4×
“Jim é nez-Luna et al. [24] describe the use of AI in synthetic organic chemistry, specifically in reaction prediction, retrosynthesis, and reaction optimization.”
BackgroundMethodInfluentialTaye, M. M. (2023) · Computers · doi:10.3390/computers12050091 · Cited by 1,057
A robotic platform for flow synthesis of organic compounds informed by AI planning
Coley, C. W., Thomas, D. A., Lummiss, J. A. M., Jaworski, J. N., Breen, C. P., Schultz, V., Hart, T., Fishman, J. S., Rogers, L., Gao, H., et al. (2019) · Science · doi:10.1126/science.aax1566 · Cited by 1,052
Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery
Yang, X., Wang, Y., Byrne, R., Schneider, G., & Yang, S. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00728 · Cited by 1,022
History of artificial intelligence in medicine
Kaul, V., Enslin, S., & Gross, S. A. (2020) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2020.06.040 · Cited by 1,011
Rethinking drug design in the artificial intelligence era
Schneider, P., Walters, W. P., Plowright, A. T., Sieroka, N., Listgarten, J., Goodnow, R. A., Fisher, J., Jansen, J. M., Duca, J. S., Rush, T. S., et al. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0050-3 · Cited by 894
Machine Learning in Drug Discovery: A Review
Dara, S., Dhamercherla, S., Jadav, S. S., Babu, C. M., & Ahsan, M. J. (2022) · Artificial Intelligence Review · doi:10.1007/s10462-021-10058-4 · Cited by 792
Protein–Ligand Scoring with Convolutional Neural Networks
Ragoza, M., Hochuli, J., Idrobo, E., Sunseri, J., & Koes, D. R. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00740 · Cited by 774
Artificial Intelligence in Medicine: Today and Tomorrow
Briganti, G., & Le Moine, O. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00027 · Cited by 743
The role of AI in drug discovery: challenges, opportunities, and strategies
Blanco-González, A., Cabezón, A., Seco-González, A., Conde-Torres, D., Antelo-Riveiro, P., Piñeiro, Á., & Garcia-Fandino, R. (2023) · Pharmaceuticals · doi:10.3390/ph16060891 · Cited by 690
Deep learning for molecular design—a review of the state of the art
Elton, D. C., Boukouvalas, Z., Fuge, M. D., & Chung, P. W. (2019) · Molecular Systems Design & Engineering · doi:10.1039/c9me00039a · Cited by 683
Artificial intelligence in COVID-19 drug repurposing
Zhou, Y., Wang, F., Tang, J., Nussinov, R., & Cheng, F. (2020) · The Lancet Digital Health · doi:10.1016/s2589-7500(20)30192-8 · Cited by 636 · cited 1×
“Yadi et al. [150] introduce guidelines on how to use AI for accelerating drug repurposing or repositioning.”
BackgroundWhat makes Big Data, Big Data? Exploring the ontological characteristics of 26 datasets
Kitchin, R., & McArdle, G. (2016) · Big Data & Society · doi:10.1177/2053951716631130 · Cited by 606
Unsupervised Machine Learning for Networking: Techniques, Applications and Research Challenges
Usama, M., Qadir, J., Raza, A., Arif, H., Yau, K.-L. A., Elkhatib, Y., Hussain, A., & Al-Fuqaha, A. (2019) · IEEE Access · doi:10.1109/access.2019.2916648 · Cited by 575
Artificial intelligence for diabetes management and decision support: Literature review
Contreras, I., & Vehi, J. (2018) · Journal of Medical Internet Research · doi:10.2196/10775 · Cited by 560
How artificial intelligence is changing drug discovery
Fleming, N. (2018) · Nature · doi:10.1038/d41586-018-05267-x · Cited by 546
Rifaioglu, A. S., Atas, H., Martin, M. J., Cetin-Atalay, R., Atalay, V., & Doğan, T. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bby061 · Cited by 529
PotentialNet for Molecular Property Prediction
Feinberg, E. N., Sur, D., Wu, Z., Husic, B. E., Mai, H., Li, Y., Sun, S., Yang, J., Ramsundar, B., & Pande, V. S. (2018) · ACS Central Science · doi:10.1021/acscentsci.8b00507 · Cited by 481
Polypharmacology: drug discovery for the future
Reddy, A. S., & Zhang, S. (2013) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.12.74 · Cited by 479
Machine Learning Methods in Drug Discovery
Patel, L., Shukla, T., Huang, X., Ussery, D. W., & Wang, S. (2020) · Molecules · doi:10.3390/molecules25225277 · Cited by 460
Optimizing Chemical Reactions with Deep Reinforcement Learning
Zhou, Z., Li, X., & Zare, R. N. (2017) · ACS Central Science · doi:10.1021/acscentsci.7b00492 · Cited by 437
Gentile, F., Yaacoub, J. C., Gleave, J., Fernandez, M., Ton, A.-T., Ban, F., Stern, A., & Cherkasov, A. (2022) · Nature Protocols · doi:10.1038/s41596-021-00659-2 · Cited by 397 · cited 4×
“AI algorithms can explore the conformational between the drug and the target protein [22].”
BackgroundMethodInfluentialTransfer Learning for Drug Discovery
Cai, C., Wang, S., Xu, Y., Zhang, W., Tang, K., Ouyang, Q., Lai, L., & Pei, J. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b02147 · Cited by 366
Improving scoring-docking-screening powers of protein-ligand scoring functions using random forest
Wang, C., & Zhang, Y. (2017) · Journal of Computational Chemistry · doi:10.1002/jcc.24667 · Cited by 334
A Review on Conventional Machine Learning vs Deep Learning
Chauhan, N. K., & Singh, K. (2018) · 2018 International Conference on Computing, Power and Communication Technologies (GUCON) · doi:10.1109/gucon.2018.8675097 · Cited by 319
Zeng, X., Xiang, H., Yu, L., Wang, J., Li, K., Nussinov, R., & Cheng, F. (2022) · Nature Machine Intelligence · doi:10.1038/s42256-022-00557-6 · Cited by 308
Boobier, S., Hose, D. R. J., Blacker, A. J., & Nguyen, B. N. (2020) · Nature Communications · doi:10.1038/s41467-020-19594-z · Cited by 307
Mechanism of baricitinib supports artificial intelligence‐predicted testing in COVID ‐19 patients
Stebbing, J., Krishnan, V., de Bono, S., Ottaviani, S., Casalini, G., Richardson, P. J., Monteil, V., Lauschke, V. M., Mirazimi, A., Youhanna, S., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202012697 · Cited by 291
Genetic Algorithms in the Fields of Artificial Intelligence and Data Sciences
Sohail, A. (2023) · Annals of Data Science · doi:10.1007/s40745-021-00354-9 · Cited by 286
Active-learning strategies in computer-assisted drug discovery
Reker, D., & Schneider, G. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2014.12.004 · Cited by 261
Virtual Screening of Molecular Databases Using a Support Vector Machine
Jorissen, R. N., & Gilson, M. K. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci049641u · Cited by 258
Choudhary, K., Kalish, I., Beams, R., & Tavazza, F. (2017) · Scientific Reports · doi:10.1038/s41598-017-05402-0 · Cited by 255
Machine Learning for Evolution Strategies
Kramer, O. (2016) · Studies in Big Data · doi:10.1007/978-3-319-33383-0 · Cited by 244
Artificial Intelligence Approaches for Rational Drug Design and Discovery
Duch, W., Swaminathan, K., & Meller, J. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207780765954 · Cited by 243
Rifaioglu, A. S., Nalbat, E., Atalay, V., Martin, M. J., Cetin-Atalay, R., & Doğan, T. (2020) · Chemical Science · doi:10.1039/c9sc03414e · Cited by 240
Prediction of physicochemical properties based on neural network modelling
Taskinen, J., & Yliruusi, J. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00117-0 · Cited by 222
CURATE.AI: Optimizing Personalized Medicine with Artificial Intelligence
Blasiak, A., Khong, J., & Kee, T. (2020) · SLAS Technology · doi:10.1177/2472630319890316 · Cited by 222
Carpenter, K. A., & Huang, X. (2018) · Current Pharmaceutical Design · doi:10.2174/1381612824666180607124038 · Cited by 197
Selvaraj, C., Chandra, I., & Singh, S. K. (2022) · Molecular Diversity · doi:10.1007/s11030-021-10326-z · Cited by 196
Vadapalli, S., Abdelhalim, H., Zeeshan, S., & Ahmed, Z. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac191 · Cited by 194
Language as a biomarker for psychosis: a natural language processing approach
Corcoran, C. M., Mittal, V. A., Bearden, C. E., E. Gur, R., Hitczenko, K., Bilgrami, Z., Savic, A., Cecchi, G. A., & Wolff, P. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.04.032 · Cited by 186 · cited 1×
“Text mining by AI models can uncover the potential biomarkers associated with specific diseases or drug responses [82].”
BackgroundOn the road to explainable AI in drug-drug interactions prediction: A systematic review
Vo, T. H., Nguyen, N. T. K., Kha, Q. H., & Le, N. Q. K. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.04.021 · Cited by 176
Mostafa, A., Kandeil, A., A. M. M. Elshaier, Y., Kutkat, O., Moatasim, Y., Rashad, A. A., Shehata, M., Gomaa, M. R., Mahrous, N., Mahmoud, S. H., et al. (2020) · Pharmaceuticals · doi:10.3390/ph13120443 · Cited by 172
PUResNet: prediction of protein-ligand binding sites using deep residual neural network
Kandel, J., Tayara, H., & Chong, K. T. (2021) · Journal of Cheminformatics · doi:10.1186/s13321-021-00547-7 · Cited by 162
Deep Learning in Drug Discovery and Medicine; Scratching the Surface
Dana, D., Gadhiya, S., Surin, L. S., Li, D., Naaz, F., Ali, Q., Paka, L., Yamin, M., Narayan, M., Goldberg, I. D., et al. (2018) · Molecules · doi:10.3390/molecules23092384 · Cited by 161
DrugRep: an automatic virtual screening server for drug repurposing
Gan, J.-H., Liu, J., Liu, Y., Chen, S., Dai, W., Xiao, Z. J., & Cao, Y. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00996-2 · Cited by 160
Deep Learning for Molecular Generation
Xu, Y., Lin, K., Wang, S., Wang, L., Cai, C., Song, C., Lai, L., & Pei, J. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0358 · Cited by 158
Lejal, N., Tarus, B., Bouguyon, E., Chenavas, S., Bertho, N., Delmas, B., Ruigrok, R. W. H., Primo, C. D., & Slama‐Schwok, A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02335-12 · Cited by 153
Hou, T., Wang, J., & Li, Y. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci7002076 · Cited by 143
Designing optimized drug candidates with Generative Adversarial Network
Abbasi, M., Santos, B. P., Pereira, T. C., Sofia, R., Monteiro, N. R. C., Simões, C. J. V., Brito, R. M. M., Ribeiro, B., Oliveira, J. L., & Arrais, J. P. (2022) · Journal of Cheminformatics · doi:10.1186/s13321-022-00623-6 · Cited by 137
GANsDTA: Predicting Drug-Target Binding Affinity Using GANs
Zhao, L., Wang, J., Pang, L., Liu, Y., & Zhang, J. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2019.01243 · Cited by 135
Programming with TensorFlow: Solution for Edge Computing Applications
(2021) · EAI/Springer Innovations in Communication and Computing · doi:10.1007/978-3-030-57077-4 · Cited by 134
ResGen is a pocket-aware 3D molecular generation model based on parallel multiscale modelling
Zhang, O., Zhang, J., Jin, J., Zhang, X., Hu, R., Shen, C., Cao, H., Du, H., Kang, Y., Deng, Y., et al. (2023) · Nature Machine Intelligence · doi:10.1038/s42256-023-00712-7 · Cited by 133
A Review of Deep Learning with Recurrent Neural Network
Kaur, M., & Mohta, A. (2019) · International Conference on Smart Systems and Inventive Technology (ICSSIT) · doi:10.1109/icssit46314.2019.8987837 · Cited by 131
Applications of Machine Learning Methods in Drug Toxicity Prediction
Zhang, L., Zhang, H., Ai, H., Hu, H., Li, S., Zhao, J. H., & Liu, H. (2018) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026618666180727152557 · Cited by 124
Lin, E., Lin, C., & Lane, H. (2020) · Molecules · doi:10.3390/molecules25143250 · Cited by 124
Baronzio, G., Parmar, G., & Baronzio, M. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00165 · Cited by 115
Seo, S., Choi, J., Park, S., & Ahn, J. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04466-0 · Cited by 109
Inside the nascent industry of AI-designed drugs
Arnold, C. (2023) · Nature Medicine · doi:10.1038/s41591-023-02361-0 · Cited by 109
Machine learning approaches and their applications in drug discovery and design
Priya, S., Tripathi, G., Singh, D. B., Jain, P., & Kumar, A. (2022) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14057 · Cited by 103
Machine Learning in Drug Discovery and Development Part 1: A Primer
Talevi, A., Morales, J. F., Hather, G. J., Podichetty, J. T., Kim, S., Bloomingdale, P., Kim, S., Burton, J. K., Brown, J. D., Winterstein, A. G., et al. (2020) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12491 · Cited by 102
Validation strategies for target prediction methods
Mathai, N., Chen, Y., & Kirchmair, J. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz026 · Cited by 99
A fingerprints based molecular property prediction method using the BERT model
Wen, N., Liu, G., Zhang, J., Zhang, R., Fu, Y., & Han, X. (2022) · Journal of Cheminformatics · doi:10.1186/s13321-022-00650-3 · Cited by 95
Using GANs with adaptive training data to search for new molecules
Blanchard, A. E., Stanley, C. B., & Bhowmik, D. (2021) · Journal of Cheminformatics · doi:10.1186/s13321-021-00494-3 · Cited by 94
An up-to-date overview of computational polypharmacology in modern drug discovery
Chaudhari, R. R., Fong, L. W. R., Tan, Z., Huang, B., & Zhang, S. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1767063 · Cited by 90
How can natural language processing help model informed drug development?: a review
Bhatnagar, R., Sardar, S., Beheshti, M., & Podichetty, J. T. (2022) · JAMIA Open · doi:10.1093/jamiaopen/ooac043 · Cited by 88
Tripathi, S., Augustin, A. I., Dunlop, A., Sukumaran, R., Dheer, S., Zavalny, A., Haslam, O., Austin, T. C., Donchez, J., Tripathi, P. K., et al. (2022) · Artificial Intelligence in the Life Sciences · doi:10.1016/j.ailsci.2022.100045 · Cited by 87
Evaluation of ADMET Predictor in Early Discovery Drug Metabolism and Pharmacokinetics Project Work
Sohlenius-Sternbeck, A.-K., & Terelius, Y. (2021) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000552 · Cited by 82
Supervised learning through physical changes in a mechanical system
Stern, M., Arinze, C., Perez, L., Palmer, S. E., & Murugan, A. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2000807117 · Cited by 81
Prospect of Artificial Intelligence Based on Electronic Medical Records
Lee, S., & Kim, H. (2021) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2021.10.3.282 · Cited by 74
Yang, C., & Zhang, Y. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00485 · Cited by 74
Guerrero, J. P., Nguewa, P., & García‐Sosa, A. T. (2021) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1513 · Cited by 73
The Potential Applications of Artificial Intelligence in Drug Discovery and Development
Farghali, H., Kutinová Canová, N., & Arora, M. (2021) · Physiological Research · doi:10.33549/physiolres.934765 · Cited by 72
Neuroprotective Drug for Nerve Trauma Revealed Using Artificial Intelligence
Romeo-Guitart, D., Forés, J., Herrando-Grabulosa, M., Valls, R., Leiva-Rodríguez, T., Galea, E., González-Pérez, F., Navarro, X., Petegnief, V., Bosch, A., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19767-3 · Cited by 71
Computational drug repurposing based on electronic health records: a scoping review
Zong, N., Wen, A., Moon, S., Fu, S., Wang, L., Zhao, Y., Yu, Y. S., Huang, M. S., Wang, Y., Zheng, G., et al. (2022) · npj Digital Medicine · doi:10.1038/s41746-022-00617-6 · Cited by 71
Gong, D. H., Ben‐Akiva, E., Singh, A., Yamagata, H. M., Est-Witte, S. E., Shade, J. K., Trayanova, N. A., & Green, J. J. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.09.072 · Cited by 71
Davis, C. R., Murphy, K. J., Curtis, R., & Maher, C. A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17239137 · Cited by 68
Fagerholm, U., Hellberg, S., & Spjuth, O. (2021) · Molecules · doi:10.3390/molecules26092572 · Cited by 66
Freedman, D. H. (2019) · Nature · doi:10.1038/d41586-019-03846-0 · Cited by 65
Text Mining for Drug Discovery
Zheng, S., Dharssi, S., Wu, M., Li, J., & Lu, Z. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9089-4_13 · Cited by 64
Markham, A. (2021) · Drugs · doi:10.1007/s40265-021-01516-y · Cited by 62
Gradual in Silico Filtering for Druglike Substances
Schneider, N., Jäckels, C., Andrés, C., & Hutter, M. C. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci700351y · Cited by 61
Computational studies of protein–drug binding affinity changes upon mutations in the drug target
Friedman, R. (2021) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1563 · Cited by 60
Artificial Intelligence in Epilepsy
Kaur, T., Diwakar, A., Kirandeep, K., Mirpuri, P., Tripathi, M., Chandra, P. S., & Gandhi, T. K. (2021) · Neurology India · doi:10.4103/0028-3886.317233 · Cited by 59
DrugRepo: a novel approach to repurposing drugs based on chemical and genomic features
Wang, Y., Aldahdooh, J., Hu, Y., Yang, H., Vähä-Koskela, M. J. V., Tang, J. P., & Tanoli, Z. (2022) · Scientific Reports · doi:10.1038/s41598-022-24980-2 · Cited by 58
Generalized Cross-Validation for Simultaneous Optimization of Tuning Parameters in Ridge Regression
Roozbeh, M., Arashi, ., & Hamzah, N. A. (2020) · Iranian Journal of Science and Technology Transactions A Science · doi:10.1007/s40995-020-00851-1 · Cited by 56
Rudrapal, M., Kırboğa, K. K., Abdalla, M., & Maji, S. (2024) · Molecular Diversity · doi:10.1007/s11030-023-10782-9 · Cited by 56
Kumar, S., & Kim, M. (2021) · Journal of Cheminformatics · doi:10.1186/s13321-021-00507-1 · Cited by 51
Terrier, O., Dilly, S., Pizzorno, A., Chalupská, D., Humpolíčková, J., Bouřa, E., Berenbaum, F., Quideau, S., Lina, B., Fève, B., et al. (2021) · Molecules · doi:10.3390/molecules26092593 · Cited by 50
Medical Image Analysis Using Artificial Intelligence
Yoon, H. J., Jeong, Y. J., Kang, H. K., Jeong, J. E., & Kang, D. (2019) · Progress in Medical Physics · doi:10.14316/pmp.2019.30.2.49 · Cited by 46
Kwak, H. S., An, Y., Giesen, D. J., Hughes, T. F., Brown, C. T., Leswing, K., Abroshan, H., & Halls, M. D. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2021.800370 · Cited by 43
Rani, P., Dutta, K., & Kumar, V. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105334 · Cited by 39
Alzain, A. A., Elbadwi, F. A., & Alsamani, F. O. (2022) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2022.100870 · Cited by 37
Machine learning approaches for biomolecular, biophysical, and biomaterials research
Rickert, C. A., & Lieleg, O. (2022) · Biophysics Reviews · doi:10.1063/5.0082179 · Cited by 34
Zhuang, D., & Ibrahim, A. K. (2021) · Applied Sciences · doi:10.3390/app11177772 · Cited by 33
Quantum convolutional neural networks for multi-channel supervised learning
(2023) · doi:10.1007/s42484-023-00130-3 · Cited by 32
Terranova, N., Jansen, M., Falk, M., & Hendriks, B. S. (2020) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-020-04184-z · Cited by 30
Plummer, R., Dean, E. J., Arkenau, H., Redfern, C. H., Spira, A. I., Melear, J. M., Chung, K. Y., Ferrer-Playan, J., Goddemeier, T., Locatelli, G., et al. (2021) · Lung Cancer · doi:10.1016/j.lungcan.2021.11.011 · Cited by 30
Use of density functional theory in drug metabolism studies
Rydberg, P., Jørgensen, F. S., & Olsen, L. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.864278 · Cited by 29
Miller, M. J., Tokgözoğlu, L. S., Parhofer, K. G., Handelsman, Y., Leiter, L. A., Landmesser, U., Brinton, E. A., & Catapano, A. L. (2022) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2022.2103541 · Cited by 26
Application of Artificial Intelligence in Gastrointestinal Endoscopy
Wu, J., Chen, J., & Cai, J. (2020) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001423 · Cited by 25
Ballantyne, C. M., Manku, M. S., Bays, H. E., Philip, S., Granowitz, C. B., Doyle, R. T., & Juliano, R. A. (2019) · Cardiology and Therapy · doi:10.1007/s40119-019-0131-8 · Cited by 24
Jang, G., Lee, T., Hwang, S., Park, C., Ahn, J., Seo, S., Hwang, Y., & Yoon, Y. (2018) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2018.09.015 · Cited by 22
Miller, E., & Hansch, C. H. (1967) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600560119 · Cited by 20
Identification of potential drug target in malarial disease using molecular docking analysis
Sahayarayan, J. J., Kulanthaivel, S. R., Nachiappan, M., Prabhu, D., Rao, R. G. R., Jeyakanthan, J., Mahmoud, A. H., Mohammed, O. B., & Morgan, A. M. A. (2020) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2020.10.019 · Cited by 19
Exploring polypharmacy with artificial intelligence: data analysis protocol
Sirois, C., Khoury, R., Durand, A., Déziel, P.-L., Bukhtiyarova, O., Chiu, Y. M., Talbot, D. C., Bureau, A., Després, P., Gagné, C., et al. (2021) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-021-01583-x · Cited by 19
Automated Virtual Design of Organic Semiconductors Based on Metal-Organic Frameworks
Mostaghimi, M., Rêgo, C. R. C., Haldar, R., Wöll, C., Wenzel, W., & Kozłowska, M. (2022) · Frontiers in Materials · doi:10.3389/fmats.2022.840644 · Cited by 18
DiNuzzo, M. (2022) · Frontiers in Drug Discovery · doi:10.3389/fddsv.2022.1019706 · Cited by 18
Cross-Adversarial Learning for Molecular Generation in Drug Design
Wu, B., Li, L., Cui, Y., & Zheng, K. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.827606 · Cited by 15
Bioinformatics and Drug Discovery
Larson, R. S. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9089-4 · Cited by 13
Hussain, A., Afzal, O., Yasmin, S., Haider, N., Altamimi, A. S. A., R., F. M., Acree, W. E., & Ramzan, M. (2023) · ACS Omega · doi:10.1021/acsomega.2c07968 · Cited by 9
3DStructGen: an interactive web-based 3D structure generation for non-periodic molecule and crystal
Chen, P., Wang, Y., Hui, Y., Gao, S., Xu, Z., Li, Y., Mo, Q., Huang, J., Tao, J., Pan, G., et al. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-0411-2 · Cited by 8
Faris, A., Ibrahim, I. M., Hadni, H., & Elhallaoui, M. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2240413 · Cited by 7
Artificial Intelligence: The New Alexander Fleming
Almallah, Z., El-Lababidi, R. M., Shamout, F. E., & Doyle, D. J. (2021) · Healthcare Informatics Research · doi:10.4258/hir.2021.27.2.168 · Cited by 6
Lim, H., Chon, K.-W., & Kim, M. (2023) · Expert Systems with Applications · doi:10.1016/j.eswa.2023.120193 · Cited by 5
Sikos, L. F., Seneviratne, O. W., & McGuinness, D. L. (2021) · Advanced information and knowledge processing · doi:10.1007/978-3-030-67681-0 · Cited by 4
Cited by
Bias in medical AI: Implications for clinical decision-making
Cross, J. L., Choma, M. A., & Onofrey, J. A. (2024) · PLOS Digital Health · doi:10.1371/journal.pdig.0000651 · Cited by 607
Future of Artificial Intelligence—Machine Learning Trends in Pathology and Medicine
Hanna, M. G., Pantanowitz, L., Dash, R., Harrison, J. H., Deebajah, M., Pantanowitz, J., & Rashidi, H. H. (2025) · Modern Pathology · doi:10.1016/j.modpat.2025.100705 · Cited by 231
Osonuga, A., Olawade, D. B., Gore, M., Rotifa, O. B., Egbon, E., Chinwah, V., & Boussios, S. (2025) · Annals of Translational Medicine · doi:10.21037/atm-25-62 · Cited by 8
Metadata
- Authors
- Visan, A. I., & Negut, I.
- Venue
- Life
- Publisher
- MDPI AG
- Published
- 2024-02-07
- Volume
- 14
- Issue
- 2
- Pages
- 233
- ISSN
- 2075-1729 (ISSN-L)
- OpenAlex
- W4391617198
- Cited by
- 279
- References
- 136
- FWCI
- 54.70
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.